Sign inJoin waitlistJoin the waitlist

HH

Hyo Han

Physician · H. Lee Moffitt Cancer Center and Research Institute

Credentials: · ·

History

H. Lee Moffitt Cancer Center and Research Institute
Present

Medical Oncology
2002–2004
Internal Medicine
1999–2002
Medical School
1995–1999

Research

Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Review · Breast Cancer Research and Treatment · 2018 · 345 citations
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
Cancer Cell · 2021 · 298 citations
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology · 2020 · 262 citations

HS
Hatem Soliman
35 papers
Brian Czerniecki
26 papers
RC
Ricardo Costa
17 papers
AS
Aixa Soyano
16 papers
Kamran Ahmed
16 papers
PF
Peter Forsyth
14 papers
Claudine Isaacs
13 papers
Hope Rugo
13 papers
Angela DeMichele
12 papers
AA
Avan Armaghani
12 papers
HY
Hsiang-Hsuan Yu
12 papers
Laura Esserman
12 papers